Source: Eur Respir J 2007; 30: 980-992
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Haworth O., Levy B. D.. Endogenous lipid mediators in the resolution of airway inflammation. Eur Respir J 2007; 30: 980-992

Member's Comments

No comment yet.

Related content which might interest you: Resolution of inflammation in airway diseases Source: Annual Congress 2005 - Mechanisms of resolution of inflammation Year: 2005 Pathology, inflammation and cytokines of severe asthma Source: Eur Respir Mon 2011; 51: 97-106 Year: 2011 An update on anti-inflammatory endogenous mediators Source: Annual Congress 2005 - Mechanisms of resolution of inflammation Year: 2005 IL-33 blockade impacts mediators of persistence and exacerbation of chronic airway inflammation. Source: International Congress 2018 – Novel drug targets for asthma and COPD Year: 2018 Airway inflammation during stable and acutely exacerbated chronic obstructive pulmonary disease Source: Eur Respir J 2005; 25: 640-646 Year: 2005 Exploitation of anti-inflammatory mechanisms for the treatment of severe asthma Source: Annual Congress 2005 - Mechanisms of resolution of inflammation Year: 2005 New anti-inflammatory activities of Alpha-1-Antitrypsin and their role in COPD Source: Annual Congress 2005 - Protease-antiprotease revisited Year: 2005 The clinical importance of measuring airway inflammation Source: Annual Congress 2005 - Are we ready for "inflammometry"? The role of eNO in asthma management Year: 2005 Resolution of acute lung injury and inflammation: a translational mouse model Source: Eur Respir J 2012; 39: 1162-1170 Year: 2012 Endogenous mediators of resolution Source: Annual Congress 2006 - Resolution of airway and tissue inflammation “ emerging concepts Year: 2006 Development of new treatments for complex chronic comorbidities Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases Year: 2006 ß2-adrenoceptor (ß2-AR) dysfunction in airway smooth muscle in severe asthma: possible role of inflammatory cytokines Source: Virtual Congress 2020 – Clinical and laboratory pharmacology in asthma Year: 2020 IL-33 blockade prevents exacerbations in a model of chronic airway inflammation by blunting persistent inflammation and remodeling Source: International Congress 2019 – Advances in asthma pharmacology Year: 2019 Rhinitis, nasal polyposis and asthma: pathological aspects Source: ISSN=1025-448x, ISBN=1-904097-19-18, page=115 Year: 2001 Inflammatory mediators in nasal lavage, induced sputum and serum of employees with rheumatic and respiratory disorders Source: Eur Respir J 2001; 18: 542-548 Year: 2001 Mucosal inflammation in idiopathic bronchiectasis: cellular and molecular mechanisms Source: Eur Respir J 2008; 31: 396-406 Year: 2008 Airway epithelial inflammatory responses and clinical parameters in COPD Source: Eur Respir J 2003; 22: 94-99 Year: 2003 Are we ready to monitor inflammation and remodelling in asthma? Source: Annual Congress 2005 - Inflammatory phenotypes of asthma and COPD: the end of traditional diagnosis, or not? Year: 2005 Bronchial inflammatory changes in wheezy infants Source: Annual Congress 2007 - Bronchial inflammation in wheezing infants and pre-school children Year: 2007 Role of neutrophils in airway inflammation in children with severe persistent asthma Source: Eur Respir J 2002; 20: Suppl. 38, 142s Year: 2002